Nigeria HIV/AIDS program get $43M PEPFAR grant
The Institute of Human Virology at the University of Maryland, USA, has received a $43.0 million award from the President's Emergency Plan for AIDS Relief to improve HIV/AIDS services in Nigeria, the Associated Press reports. The PEPFAR program was launched by US President George W Bush in 2003 .
The IHV's founder and director, Robert Gallo, said: "this new award enables us to reach even more people who need the care and treatment provided by our institute's experts." The funds will be distributed via the AIDS Care and Treatment in Nigeria program (ACTION) and could provide 48,000 people with drugs and a further 100,000 with HIV testing and counselling, the AP said.
One course favored by the PEPFAR is providing a short course of drugs to pregnant women, which the program's administrators claim has prevented about 100,000 newborns worldwide from contracting the disease (Marketletter June 4).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze